RxDoctor Payments Data

Ronnie Pollard, DPM

Foot & Ankle Surgery · Castle Rock, CONPI 1013206317

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by International Life Sciences at 27.9% of the total. Reporting peaked in 2024 at $2,634 and has fallen 65.8% since, to $902 in 2025.

$8,507in general payments, 2019–2025

Across 78 payments — averaging $109.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Life Sciences$2K
  • Medline Industries LP$2K
  • Gemini Mountain Medical, LLC$1K
  • Smith+Nephew$1K
  • Stryker$973
  • Paragon 28, Inc.$783
  • plus $654 from 12 others

What the payments were for

  • Travel & lodging$4,79056%
  • Food & beverage$2,51730%
  • Education$1,20014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,507 in reported general payments places this provider in the 70th percentile of 181 foot & ankle surgery providers in Colorado.

See all foot & ankle surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$94,320
Medicare patients
287
Services billed
1,230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox11$507
Cephalexin45$401
Terbinafine Hcl14$319
Methylprednisolone25$211
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$155
Oxycodone Hcl33$142
Clindamycin Hcl12$88
Diclofenac Sodium11$87

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Castle Rock

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →